Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?

Mult Scler Relat Disord. 2015 May;4(3):284-6. doi: 10.1016/j.msard.2015.03.008. Epub 2015 Apr 14.

Authors

Eavan Mc Govern¹, Eoin P Judge², Eoin Kavanagh³, Sean Gaine², Timothy Lynch⁴

Affiliations

¹ Dublin Neurological Instituteat the Mater Misercordiae University Hospital , Dublin, Ireland.
² National Pulmonary Hypertension Unit, Mater university Hospital, Dublin, Ireland.
³ Department of Radiology, Mater University Hospital, Dublin, Ireland.
⁴ Dublin Neurological Instituteat the Mater Misercordiae University Hospital , Dublin, Ireland. Electronic address: tlynch@dni.ie.

PMID: 26008947
DOI: 10.1016/j.msard.2015.03.008

No abstract available

Keywords: Relapsing remitting multiple sclerosis; Treatment; Treatment side effects.

Publication types

Case Reports
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Hypertension, Pulmonary / chemically induced*
Hypertension, Pulmonary / diagnosis*
Immunologic Factors / adverse effects*
Interferon-beta / adverse effects*
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / complications*
Multiple Sclerosis, Relapsing-Remitting / drug therapy

Substances

Immunologic Factors
Interferon-beta

Grant support

R01 NS078837-02/NS/NINDS NIH HHS/United States